Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein.
You can now log in once to listen live, watch live, join competitions, enjoy exclusive 3AW content and other benefits.
You will soon need to register to keep streaming 3AW online. Register an account or skip for now to do it later.